Monitor the Q4 2026 earnings call for Gardner-Smith's strategic priorities and any guidance updates under the new leadership team. The creation of a Chief Commercial Officer role signals a push for commercial discipline and growth focus.
Price Chart
Executive Summary
Accendra Health announced a planned CEO transition, naming board member Kenneth Gardner-Smith as the next President and CEO to succeed retiring Edward Pesicka, and created a new Chief Commercial Officer role filled by Scott Lloyd. The filing is a routine leadership succession announcement with no financial results or guidance, making it neutral in sentiment.
Key Facts
- Kenneth Gardner-Smith named next President and CEO, expected to assume role early Q4 2026
- Gardner-Smith has served on the Board since March 2022 and was identified as a potential successor years ago
- Edward Pesicka retiring as previously announced; will serve as advisor post-transition
- Scott Lloyd named Chief Commercial Officer, effective October 5, 2026 — a newly created position
- Gardner-Smith's compensation includes $1M base salary, 130% target bonus, $6M annual LTI target, $650K sign-on bonus, and $2M inducement SARs grant
Financial Impact
No financial impact disclosed; CEO transition compensation package totals approximately $9.65M in first-year target value (salary + bonus + LTI + sign-on + inducement grant)
Risk Factors
- CEO transition execution risk — new leadership may shift strategy or fail to deliver on growth initiatives
- Retention risk for key talent during leadership change
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-108405 |
| Document: ach-20260916xex99d1.htm | 0001104659-26-108405 |
| Document: ach-20260916xex10d1.htm | 0001104659-26-108405 |
| Document: 0001104659-26-108405-index-headers.html | 0001104659-26-108405 |
| Document: 0001104659-26-108405-index.html | 0001104659-26-108405 |
| Document: 0001104659-26-108405.txt | 0001104659-26-108405 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | 8-K | $0.3905 $0.2202 | ▲ +43.61% | ▲ +42.12% | $0.2031 (+47.99%) |
Oct 7, 2026 20d ago | SC 13G | $0.4729 $0.3128 | ▼ −33.85% | ▼ −32.87% | $0.2031 (−57.05%) |
Sep 17, 2026 5w ago | 8-K | $1.03 $0.7332 | ▼ −28.82% | ▼ −29.42% | $0.2031 (−80.28%) |
Aug 17, 2026 10w ago | 8-K | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2031 (−81.02%) |
Aug 16, 2026 10w ago | Institutional Cluster | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2031 (−81.02%) |
Aug 10, 2026 11w ago | 8-K | $1.26 $1.13 | ▼ −10.32% | ▼ −9.91% | $0.2031 (−83.88%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▲ +23.57% | ▲ +23.52% | $0.2031 (+85.49%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▼ −23.57% | ▼ −23.52% | $0.2031 (−85.49%) |
Jul 27, 2026 13w ago | EFFECT | $3.22 $3.41 | ▲ +5.90% | ▲ +3.39% | $0.2031 (−93.69%) |
Jun 25, 2026 17w ago | 8-K | $3.34 $3.59 | ▲ +7.49% | ▲ +5.32% | $0.2031 (−93.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers